The big biotech, which has made genetic medicine a focus in recent years, is paying Tessera $150 million for rights to a ...

If approved, Regeneron and Tessera's TSRA-196 could become the first curative therapy to reach patients with AATD, who have ...

CRISPR technology, a revolutionary tool in genetic engineering, has empowered Lambert's iGEM team to tackle a significant health issue: Lyme disease, which affects nearly half a million Americans ...

The Lambert High School team, consisting of young genetic engineers led by Sean Lee and Avani Karthik, aimed to address a significant issue: the difficulty in diagnosing Lyme disease during its early ...

Teens at a Georgia high school may have come up with a better way to detect and treat Lyme disease. They took their idea to ...

To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...

A groundbreaking new study reveals a gene-editing therapy that dramatically lowered 'bad' cholesterol in monkeys, offering ...

But sometimes, this top investor who focuses on innovation does see eye-to-eye with analysts, and the perfect example of this ...

CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the best short squeeze stocks to buy right now. Citizens reaffirmed its ...

After releasing two gene-edited rice varieties in May this year, scientists are now focusing on developing GE varieties of ...

Key breakthrough for the return of the dodo: viable cells have been obtained and genetically modified birds have been prepared.

To compile our list of the best short squeeze stocks, we made use of stocks screeners to note down stocks with significant ...